CoChat
Sign Up
Cited by 315Tuberculosis Research and EpidemiologyInfectious Diseases and TuberculosisHIV, TB, and STIs Epidemiology

The DOI matches its Crossref record; 25 of the 27 references it cites were found in a registry or an index.

Subclinical Tuberculosis Disease—A Review and Analysis of Prevalence Surveys to Inform Definitions, Burden, Associations, and Screening Methodology

Open access
Frascella, Beatrice, Richards, Alexandra S, Sossen, Bianca, Emery, Jon C, Odone, Anna, Law, Irwin, Onozaki, Ikushi, Esmail, Hanif, Houben, Rein M G J·2021·Clinical Infectious Diseases
DOI 10.1093/cid/ciaa1402PMC PMC8326537
Open this paper in CoChat — free accountOpen PDF

Abstract

While it is known that a substantial proportion of individuals with tuberculosis disease (TB) present subclinically, usually defined as bacteriologically-confirmed but negative on symptom screening, considerable knowledge gaps remain. Our aim was to review data from TB prevalence population surveys and generate a consistent definition and framework for subclinical TB, enabling us to estimate the proportion of TB that is subclinical, explore associations with overall burden and program indicators, and evaluate the performance of screening strategies. We extracted data from all publicly available prevalence surveys conducted since 1990. Between 36.1% and 79.7% (median, 50.4%) of prevalent bacteriologically confirmed TB was subclinical. No association was found between prevalence of subclinical and all bacteriologically confirmed TB, patient diagnostic rate, or country-level HIV prevalence (P values, .32, .4, and .34, respectively). Chest Xray detected 89% (range, 73%–98%) of bacteriologically confirmed TB, highlighting the potential of optimizing current TB case-finding policies.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1093/cid/ciaa1402

Cites

25 of 25 references verified0 citation errors · 0 not checkable

Statistics

Figures

Figure 1. Selection flow chart for tuberculosis prevalence surveys.
Figure 1. Selection flow chart for tuberculosis prevalence surveys.CC BY-NC-ND · PubMed Central
Figure 2. Proportion of subclinical tuberculosis disease (TB) in prevalence surveys. The proportion of all prevalent TB cases that were subclinical (bars: left side y-axis) by the adult crude prevalence of bacteriologically confirmed TB found in that survey (crosses: right side y-axis). The first 3 bars show the median (bar) and interquartile range (error bars) for values found in surveys in Africa, Asia, and overall. Abbreviations: DPR, Democratic People’s Republic; PDR, People’s Democratic Republic; sub, subnational surveys.
Figure 2. Proportion of subclinical tuberculosis disease (TB) in prevalence surveys. The proportion of all prevalent TB cases that were subclinical (bars: left side y-axis) by the adult crude prevalence of bacteriologically confirmed TB found in that survey (crosses: right side y-axis). The first 3 bars show the median (bar) and interquartile range (error bars) for values found in surveys in Africa, Asia, and overall. Abbreviations: DPR, Democratic People’s Republic; PDR, People’s Democratic Republic; sub, subnational surveys.CC BY-NC-ND · PubMed Central
Figure 3. Screening modality for bacteriologically confirmed tuberculosis disease (TB) cases. The proportion of bacteriologically confirmed cases in prevalence surveys that screened positive on X ray (y-axis) or on symptom screen only (x-axis). Raw data are available in Table 3. Note: The Vietnam 2007 and Sudan 2014 surveys did not report symptom screening and X-ray results for TB cases who were under treatment or had a history of treatment within 2 years but did receive bacteriological examination. In the Philippines 2016 survey, 5% of bacteriologically confirmed cases were exempted from X ray (see Table 1). Abbreviations: DPR, Democratic People’s Republic; PDR, People’s Democratic Republic.
Figure 3. Screening modality for bacteriologically confirmed tuberculosis disease (TB) cases. The proportion of bacteriologically confirmed cases in prevalence surveys that screened positive on X ray (y-axis) or on symptom screen only (x-axis). Raw data are available in Table 3. Note: The Vietnam 2007 and Sudan 2014 surveys did not report symptom screening and X-ray results for TB cases who were under treatment or had a history of treatment within 2 years but did receive bacteriological examination. In the Philippines 2016 survey, 5% of bacteriologically confirmed cases were exempted from X ray (see Table 1). Abbreviations: DPR, Democratic People’s Republic; PDR, People’s Democratic Republic.CC BY-NC-ND · PubMed Central
Figure 4. Population screening results. The proportion of population included in prevalence surveys that screened positive on X ray, symptom screen, both, or neither. Abbreviations: DPR, Democratic People’s Republic; PDR, People’s Democratic Republic.
Figure 4. Population screening results. The proportion of population included in prevalence surveys that screened positive on X ray, symptom screen, both, or neither. Abbreviations: DPR, Democratic People’s Republic; PDR, People’s Democratic Republic.CC BY-NC-ND · PubMed Central
Figure 5. Model representation of the natural history of Mycobacterium tuberculosis (Mtb) infection and tuberculosis disease. Different states of Mtb infection (green) and tuberculosis disease are shown (purple). Infected individuals can progress and regress across the spectrum. Clinical disease: bacteriologically confirmed and symptomatic; incipient disease, transition from minimal to subclinical disease; infected, viable Mtb infection with potential to progress to disease; minimal disease, pathological changes caused by Mtb, but bacteriologically negative; naive-infected-minimal-incipient-subclnical-clinical-self-cleared, individual has cleared the Mtb infection and cannot progress to disease without reinfection (dashed arrows); subclinical disease, bacteriologically confirmed, negative at symptom screening.
Figure 5. Model representation of the natural history of Mycobacterium tuberculosis (Mtb) infection and tuberculosis disease. Different states of Mtb infection (green) and tuberculosis disease are shown (purple). Infected individuals can progress and regress across the spectrum. Clinical disease: bacteriologically confirmed and symptomatic; incipient disease, transition from minimal to subclinical disease; infected, viable Mtb infection with potential to progress to disease; minimal disease, pathological changes caused by Mtb, but bacteriologically negative; naive-infected-minimal-incipient-subclnical-clinical-self-cleared, individual has cleared the Mtb infection and cannot progress to disease without reinfection (dashed arrows); subclinical disease, bacteriologically confirmed, negative at symptom screening.CC BY-NC-ND · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 27 references

Research works printed but not linked: 2

  1. World Health Organization, 2013, Systematic screening for active tuberculosis: principles and recommendations
  2. 2017, Consensus meeting report: development of a target product profile (TPP) and a framework for evaluation for a test for predicting progression from tuberculosis infection to active disease

Cited by

Sorted by citations

Related

See all

Metadata

Authors
Frascella, B., Richards, A. S., Sossen, B., Emery, J. C., Odone, A., Law, I., Onozaki, I., Esmail, H., & Houben, R. M. G. J.
Affiliations
  • Vita-Salute San Raffaele University (IT)
  • London School of Hygiene & Tropical Medicine (GB)
  • University of Cape Town (ZA)
  • World Health Organization (CH)
Corresponding author
Houben, Rein M G J
ORCID
Venue
Clinical Infectious Diseases
Publisher
Oxford University Press (OUP)
Published
2020-09-16
Volume
73
Issue
3
Pages
e830-e841
ISSN
  • 1058-4838 (ISSN-L)
  • 1537-6591
DOI
10.1093/cid/ciaa1402
PMC
PMC8326537
OpenAlex
W3087646693
Cited by
315
References
27
Citations by year
2026: 49 · 2025: 65 · 2024: 63 · 2023: 57 · 2022: 46 · 2021: 30 · 2020: 5
FWCI
4.53
Type
journal article
Language
en
Open access
Licence
Locations
  • Clinical Infectious Diseases (publishedVersion, cc-by-nc-nd)
  • PubMed Central (publishedVersion, cc-by-nc-nd)
  • PubMed (publishedVersion)
  • ENLIGHTEN (Jurnal Bimbingan dan Konseling Islam) (submittedVersion, cc-by-nc-sa)
  • LSHTM Research Online (London School of Hygiene and Tropical Medicine) (submittedVersion, cc-by-nc-sa)
  • UCL Discovery (University College London) (submittedVersion)
Funders
European Research Council starting (757699)
Topics
  • Health Sciences › Medicine › Infectious Diseases › Tuberculosis Research and Epidemiology
  • Health Sciences › Medicine › Infectious Diseases › Infectious Diseases and Tuberculosis
  • Health Sciences › Medicine › Public Health, Environmental and Occupational Health › HIV, TB, and STIs Epidemiology
Keywords
subclinical tuberculosis, bacteriologically confirmed tuberculosis, prevalence survey, tuberculosis screening, chest radiography, case finding, HIV coinfection, diagnostic rate, tuberculosis burden
MeSH terms
Humans, Mass Screening, Surveys and Questionnaires, Thorax, Tuberculosis, Prevalence

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review